1102 The HLA-E/NKG2A axis is a dominant immunomodulatory pathway associated with distinct tumor microenvironment features in a subset of NSCLC

• Rakesh Kumar,
• Roy S Herbst,
• Sarah Goldberg,
• Zachary A Cooper,
• Kurt Schalper,
• Kerryan Ashley,
• Krishna Iyer

Affiliations

Rakesh Kumar

2AstraZeneca, Gaithersburg, MD, USA

Roy S Herbst

1Yale University, New Haven, CT, USA

Sarah Goldberg

1Yale University, New Haven, CT, USA

Zachary A Cooper

2AstraZeneca, Gaithersburg, MD, USA

Kurt Schalper

1Yale University, New Haven, CT, USA

Kerryan Ashley

1Yale University, New Haven, CT, USA

Krishna Iyer

1Yale University, New Haven, CT, USA